Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 5371875, 8 pages
http://dx.doi.org/10.1155/2016/5371875
Research Article

Etiologic Agents of Bacterial Sepsis and Their Antibiotic Susceptibility Patterns among Patients Living with Human Immunodeficiency Virus at Gondar University Teaching Hospital, Northwest Ethiopia

1Department of Medical Microbiology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia
2Department of Microbiology, Immunology and Parasitology, Addis Ababa University, Addis Ababa, Ethiopia
3Department of Medical Biotechnology, School of Medicine, Flinders University, Bedford Park, SA 5042, Australia

Received 30 December 2015; Revised 20 April 2016; Accepted 3 May 2016

Academic Editor: David A. Hildeman

Copyright © 2016 Gelila Alebachew et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. C. Angus, W. T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo, and M. R. Pinsky, “Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care,” Critical Care Medicine, vol. 29, no. 7, pp. 1303–1310, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Lever and I. Mackenzie, “Sepsis: definition, epidemiology, and diagnosis,” The British Medical Journal, vol. 335, no. 7625, pp. 879–883, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. B. A. Cunha, “Sepsis and septic shock: selection of empiric antimicrobial therapy,” Critical Care Clinics, vol. 24, no. 2, pp. 313–334, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Jean-Baptiste, “Cellular mechanisms in sepsis,” Journal of Intensive Care Medicine, vol. 22, no. 2, pp. 63–72, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Latif, M. S. Anwar, and I. Ahmad, “Bacterial pathogens responsible for blood stream infection and pattern of drug resistance in a tertiary care hospital of Lahore,” Biomedica, vol. 25, pp. 101–105, 2009. View at Google Scholar
  6. T. van der Poll and S. M. Opal, “Host-pathogen interactions in sepsis,” The Lancet Infectious Diseases, vol. 8, no. 1, pp. 32–43, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Sun, B. Raisley, M. Langer et al., “Anti-peptidoglycan antibodies and Fcγ receptors are the key mediators of inflammation in gram-positive sepsis,” Journal of Immunology, vol. 189, no. 5, pp. 2423–2431, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. A. C. Cheng, T. E. West, D. Limmathurotsakul, and S. J. Peacock, “Strategies to reduce mortality from bacterial sepsis in adults in developing countries,” PLoS Medicine, vol. 5, no. 8, article e175, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Bane, A. G. Yohannes, and D. Fekade, “Morbidity and mortality of adult patients with HIV/AIDS at Tikur Anbessa Teaching Hospital, Addis Ababa, Ethiopia,” Ethiopian Medical Journal, vol. 41, no. 2, pp. 131–140, 2003. View at Google Scholar · View at Scopus
  10. K. D. Waikhom and K. S. Devi, “Emergence of multidrug resistant bacterial infection in HIV/AIDS cases,” The Health, vol. 3, pp. 49–52, 2012. View at Google Scholar
  11. Clinical and Laboratory Standard Institution, “Principles and procedures for blood culture; approved guideline,” Clinical and Laboratory Standard Institution Document M47-A, Clinical and Laboratory Standard Institution, Wayne, Pa, USA, 2007. View at Google Scholar
  12. Clinical and Laboratory Standards Institute, Performance Standards for Antimicrobial Disk Susceptibility Tests, Clinical and Laboratory Standards Institute Document M2-A9, Clinical and Laboratory Standards Institute, Wayne, Pa, USA, 9th edition, 2006.
  13. B. Liu, L. Zhang, R. Guo, J. Su, L. Li, and Y. Si, “Anti-infective treatment in HIV-infected patients during perioperative period,” AIDS Research and Therapy, vol. 9, article 36, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. H. B. Jaspan, L. C. Huang, M. F. Cotton, A. Whitelaw, and L. Myer, “Bacterial disease and antimicrobial susceptibility patterns in HIV-infected, hospitalized children: a retrospective cohort study,” PLoS ONE, vol. 3, no. 9, article e3260, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. M. D. Burkey, L. E. Wilson, R. D. Moore, G. M. Lucas, J. Francis, and K. A. Gebo, “The incidence of and risk factors for MRSA bacteraemia in an HIV-infected cohort in the HAART era,” HIV Medicine, vol. 9, no. 10, pp. 858–862, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. M. J. Cenizal, R. D. Hardy, M. Anderson, K. Katz, and D. J. Skiest, “Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus (MRSA) nasal colonization in HIV-infected ambulatory patients,” Journal of Acquired Immune Deficiency Syndromes, vol. 48, no. 5, pp. 567–571, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. A. I. Adeyemi, A. A. Sulaiman, B. B. Solomon, O. A. Chinedu, and I. A. Victor, “Bacterial bloodstream infections in HIV-infected adults attending a lagos teaching hospital,” Journal of Health, Population and Nutrition, vol. 28, no. 4, pp. 318–326, 2010. View at Google Scholar · View at Scopus